SUPT16H-associated neurodevelopmental disorder and neurocristopathy: genetic and phenotypic spectrum
Human Molecular Genetics · 23.02.2026 · 35 (4)
DOI: 10.1093/hmg/ddag003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 20.01.2026. Verfasst von Eunhye Lee und 51 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, DNA-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
SUPT16H encodes a subunit of the FACT (FAcilitates Chromatin Transcription) complex, a histone chaperone essential for maintaining chromatin integrity during transcription, replication, and DNA repair. Pathogenic de novo SUPT16H missense variants have previously been linked to neurodevelopmental disorders in eight individuals. Here, we expand the genotypic and phenotypic spectrum by identifying 24 additional individuals harboring ultrarare heterozygous missense or truncating variants, who share overlapping clinical features including intellectual disability, autism spectrum disorder, hypotonia, and characteristic craniofacial dysmorphism. To elucidate the underlying mechanisms, we generated a supt16h knockout zebrafish model using CRISPR/Cas9. The supt16h loss-of-function (LOF) model recapitulated key patient phenotypes such as developmental delay, craniofacial anomalies, and hypotonia. Structural and functional analyses of selected SUPT16H variants demonstrated differential rescue of developmental defects in supt16h-deficient embryos, indicating variant-specific LOF effects in vivo. The presence of non-neural manifestations, including facial and ear anomalies, suggested a role for SUPT16H in neural crest development. Consistently, supt16h loss impaired neural crest cell migration and differentiation and triggered p53-dependent apoptosis in the central nervous system (CNS) and neural crest–derived pharyngeal arches. Notably, supt16h deficiency impaired oligodendrocyte specification in the CNS and perturbed differentiation of neural crest–derived Schwann cells in the peripheral nervous system, providing a plausible basis for hypotonia. These findings uncover a previously unrecognized role of SUPT16H in neural crest development, linking chromatin regulation to neural crest-derived lineage specification and differentiation, thereby defining SUPT16H deficiency as a neurocristopathy that broadens the clinical and mechanistic landscape of SUPT16H-associated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea.
- School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea.
- Department of Neurology, University of California, San Francisco, CA 94158, United States.
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, United States.
- Department of Genomic Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
- Department of Pediatrics, University of Illinois Chicago, Chicago, IL 60607, United States.
ORCID-Profile: Hee-Jung Choi, Sylvie Odent, Murim Choi, Jong-Hee Chae, Yun Kee, Emanuela Argilli
Förderung
- NINDS NIH HHS
Zitieren
APA
Lee, E., Sim, S., Choi, H. J., Liang, E. Y., Le, C., Bina, R., Cohen, R., George, E., Kim, S. Y., Bhat, G., Falsey, E., Sidlow, R., Clinard, K., Ben-Shachar, S., England, E., Menendez, B., Herman, I., Nielsen, S., Punetha, J., …, & Argilli, E. (2026). SUPT16H-associated neurodevelopmental disorder and neurocristopathy: genetic and phenotypic spectrum. Human Molecular Genetics, 35(4). https://doi.org/10.1093/hmg/ddag003
Vancouver
Lee E, Sim S, Choi HJ, Liang EY, Le C, Bina R, et al. SUPT16H-associated neurodevelopmental disorder and neurocristopathy: genetic and phenotypic spectrum. Human Molecular Genetics. 2026;35(4). doi:10.1093/hmg/ddag003
BibTeX
@article{Lee2026,
author = {Lee, Eunhye and Sim, Seungmin and Choi, Hee-Jung and Liang, Eugene Y and Le, Carolyn and Bina, Roya and Cohen, Ryan and George, Elizabeth and Kim, Soo Yeon and Bhat, Gifty and Falsey, Erin and Sidlow, Richard and Clinard, Kristin and Ben-Shachar, Shay and England, Eleina and Menendez, Beatriz and Herman, Isabella and Nielsen, Shelly and Punetha, Jaya and Bhola, Priya and Hamm, J Austin and Keeney, Megan A and Sitzman, Nike and Berger, Sara and Mehta, Lakshmi and Conn, Alison J and Downie, Lilian and Ashfaq, Myla and Northrup, Hope and Bruel, Ange-Line and Odent, Sylvie and Szot, Justin O and Martinez, Noelia Nunez and Park, Sunju and Refkin, Julie and Good, Jean-Marc and Maurer, Fabienne and Le Caignec, Cédric and Coman, David J and Anderson, Erin and Richards, Linda J and Dean, Ryan J and Yang, Caleb and Choi, Chulwon and Hwang, Byung Joon and Lee, Jin Sook and Dobyns, William B and Choi, Murim and Sherr, Elliott H and Chae, Jong-Hee and Kee, Yun and Argilli, Emanuela},
title = {SUPT16H-associated neurodevelopmental disorder and neurocristopathy: genetic and phenotypic spectrum},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {4},
doi = {10.1093/hmg/ddag003}
}
EUVIMED